Procurement of Essential Pharmaceutical Tablets for Indian Army

TENDER DESCRIPTION

This tender, issued by the Department of Military Affairs, Ministry of Defence, under Bid Number GEM/2026/B/8130813, is for the procurement of a comprehensive range of pharmaceutical tablets for the Indian Army. The bid period commences on November 2, 2026, at 10:50 AM and concludes on November 23, 2026, at 12:00 PM. The total estimated quantity for this procurement is 1,438,265 units. The tender encompasses a diverse array of medications, including but not limited to Pramipexole ER 1.5 mg, Propranolol 10 mg, Propranolol TR 40 mg, Prucalopride 1 mg, Pyridoxine (40 mg and 10 mg), Quetiapine 50 mg, Ramipril 10 mg, Rasagiline 0.5 mg, Risperidone 1 mg, Rosuvastatin 40 mg, Selegiline HCl 5 mg, Serratiopeptidase 10 mg, Sertraline (100 mg and 50 mg), Silodosin 4 mg with Dutasteride 0.5 mg, Sodium Picosulphate 10 mg, Sodium Valporate 200 mg, Sofosbuvir 400 mg with Velpatasvir 100 mg, Solifenacin Succinate 5 mg, Sumatriptan 50 mg, Tadalafil 20 mg, Tapentadol 50 mg, Taurine 500 mg with N-Acetylcysteine 150 mg, Telmisartan (20 mg, 40 mg with Chlorthalidone 12.5 mg, and 80 mg with HCTZ 12.5 mg), Tenofovir 300 mg with Lamivudine 300 mg and Efavirenz 600 mg, Thalidomide 50 mg, Thiamine 100 mg, Thiocolchicoside (4 mg and 8 mg), Tolperisone 150 mg, Tolterodine 1 mg, Topiramate 25 mg, Torsemide (10 mg with Spironolactone 50 mg, 5 mg with Spironolactone 25 mg, and 5 mg), Tramadol with Dicyclomine and Acetaminophen (Parvon Spas), Trazodone 50 mg, Trihexyphenidyl HCl 2 mg, Trimetazidine (20 mg and SR 60 mg), Trypsin and Chymotrypsin (6-in-1, 100000 AU Enteric Coated), and Ubidecarenone 300 mg, Valsartan 40 mg. Prospective bidders are invited to submit their proposals in response to this critical requirement for the armed forces.